Fenofibrate 160 , 200 & 267 mg

Products

Information

Fenofibrate is a third generation fibric acid practically insoluble in water, making it challenging to consistently achieve therapeutic levels1, 2. Micronization technology dramatically improves the dissolution rate-limited gastrointestinal absorption.
All categories
Anatomical Therapeutic Chemical (ATC) Classification ProductsCardiovascular SystemProducts
Main Categories
Anatomical Therapeutic Chemical (ATC) Classification Products
ATHENAAthena, a French based MNC, is dedicated to developing life-cycle products, with a broad range of technology platforms for oral delivery with a distinctive focus on modified release formulation as well as oro-dispersible dosage forms. Using these technologies Athena has developed a wide range of products in various therapeutic segments like Pain, CNS, Cardiometabolic, Gastroenterology, Gynaecology and more. Athena Pharmaceutiques has two R&D as well as manufacturing units located in Athena IPS, France and Athena DDS, India. Athena is primarily engaged in a Licensing and Supply business model. We can supply products in Finished form as ODT, Tablet, Capsules, Sachets or Semi-finished form as bulk granules for direct compression and pellets for encapsulation/sachets filing. Athena facilities are approved by EU-GMP, Health Canada, TGA- Australia, ANVISA, RUSSIA, SAPHRA and other countries.

Log in

See all the content and easy-to-use features by logging in or registering!